Masimo Co. (NASDAQ:MASI) EVP Yongsam Lee sold 5,900 shares of the stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $88.31, for a total transaction of $521,029.00. Following the sale, the executive vice president now directly owns 70,800 shares of the company’s stock, valued at approximately $6,252,348. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Yongsam Lee also recently made the following trade(s):

  • On Monday, December 4th, Yongsam Lee sold 18,198 shares of Masimo stock. The stock was sold at an average price of $88.85, for a total transaction of $1,616,892.30.
  • On Thursday, November 9th, Yongsam Lee sold 13,976 shares of Masimo stock. The stock was sold at an average price of $89.43, for a total transaction of $1,249,873.68.
  • On Wednesday, November 1st, Yongsam Lee sold 5,000 shares of Masimo stock. The stock was sold at an average price of $89.89, for a total transaction of $449,450.00.

Shares of Masimo Co. (NASDAQ:MASI) traded down $0.41 during trading hours on Monday, reaching $88.47. 559,709 shares of the company’s stock traded hands, compared to its average volume of 612,924. Masimo Co. has a one year low of $60.31 and a one year high of $104.71. The firm has a market capitalization of $4,592.53, a P/E ratio of 34.05, a price-to-earnings-growth ratio of 2.99 and a beta of 0.72.

Masimo (NASDAQ:MASI) last issued its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.17. Masimo had a net margin of 45.83% and a return on equity of 22.17%. The company had revenue of $193.69 million during the quarter, compared to the consensus estimate of $189.01 million. During the same quarter last year, the company earned $0.52 earnings per share. Masimo’s revenue for the quarter was up 15.6% on a year-over-year basis. equities analysts predict that Masimo Co. will post 2.95 EPS for the current fiscal year.

A number of large investors have recently modified their holdings of MASI. BlackRock Inc. grew its position in Masimo by 7.5% in the second quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock valued at $721,710,000 after acquiring an additional 550,995 shares in the last quarter. Koch Industries Inc. grew its position in Masimo by 5,053.7% in the second quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock valued at $439,000 after acquiring an additional 435,325 shares in the last quarter. JPMorgan Chase & Co. grew its position in Masimo by 76.3% in the second quarter. JPMorgan Chase & Co. now owns 802,698 shares of the medical equipment provider’s stock valued at $73,191,000 after acquiring an additional 347,360 shares in the last quarter. Vanguard Group Inc. grew its position in Masimo by 6.9% in the second quarter. Vanguard Group Inc. now owns 4,935,693 shares of the medical equipment provider’s stock valued at $450,036,000 after acquiring an additional 318,060 shares in the last quarter. Finally, Capital Fund Management S.A. grew its position in Masimo by 559.8% in the second quarter. Capital Fund Management S.A. now owns 360,189 shares of the medical equipment provider’s stock valued at $32,842,000 after acquiring an additional 305,596 shares in the last quarter. 83.74% of the stock is owned by institutional investors.

A number of analysts recently issued reports on MASI shares. Zacks Investment Research raised shares of Masimo from a “hold” rating to a “buy” rating and set a $98.00 target price for the company in a research report on Thursday, November 2nd. Stifel Nicolaus reissued a “buy” rating and set a $108.00 target price on shares of Masimo in a research report on Friday, November 3rd. BTIG Research raised shares of Masimo from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research report on Monday, August 14th. Finally, BidaskClub downgraded shares of Masimo from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $97.17.

WARNING: This article was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was illegally copied and reposted in violation of US and international copyright legislation. The correct version of this article can be read at https://www.watchlistnews.com/insider-selling-masimo-co-masi-evp-sells-5900-shares-of-stock/1744011.html.

Masimo Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Insider Buying and Selling by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.